Advances in Hepatology

Luis Rodrigo, Ian Martins, Xiaozhong Guo , Xingshun Qi

$435.95 $392.34

Hardback

Not in-store but you can order this
How long will it take?

Availability Information

We source books from suppliers in Australia and overseas. For books we don't currently have in stock, the time it takes to get them from our suppliers can vary widely - from a few days to a few months - so we check each book with each supplier to determine the expected time it will take to be supplied to us.

We then advise you accordingly. If the time taken to get any book is too long for you, you can let us know and we will cancel or adjust your order, and refund as required.

To find out the anticipated arrival time for specific items prior to ordering, please contact us by phone or email:

Phone +61 2 9264 3111, or 1800 4 BOOKS (1800 4 26657) if outside Sydney:
option 1 Abbey's Bookshop (Crime, History, Science, Kids & more) • info@abbeys.com.au
option 2 Language Book Centre (ESL & Foreign Languages) • language@abbeys.com.au
option 3 Galaxy Bookshop (Sci-fi, Fantasy, Romance, Graphic Novels) • sf@galaxybooks.com.au

QTY:

English

IntechOpen
28 July 2021

Hepatology

Summary
Details

This book discusses clinical advances in hepatology, with a focus on metabolic diseases and chronic hepatitis C. The development of direct-acting antiviral (DAA) agents for the treatment of hepatitis C virus (HCV) infection in 2010 has completely transformed the management of this disease. This transformative nature of DAA therapy underpins the goal of the World Health Organization (WHO) to eliminate HCV infection as a public health threat by 2030. The advantages of using these therapies include high efficacy (sustained virological response rate >95%) with minimal side effects, good tolerability, easy drug administration (once-daily oral dosing) and short duration of treatment (8-12 weeks). The commercialization of second-generation DAA agents due to their high effectiveness, few side-effects and pangenotypic action. This transformative nature of DAA therapy underpins the goal of the WHO to eliminate HCV infection as a public health threat by 2030.

Edited by: Luis Rodrigo, Ian Martins, Xiaozhong Guo, Xingshun Qi
Imprint: IntechOpen
Country of Publication: United Kingdom
Dimensions: Height: 260mm, Width: 180mm,
ISBN: 9781839686238
ISBN 10: 1839686235
Pages: 258
Publication Date: 28 July 2021
Audience: Professional and scholarly , Undergraduate
Format: Hardback
Publisher's Status: Active

PERHAPS A GIFT VOUCHER FOR MUM?: MOTHER'S DAY

Advances in Hepatology

Luis Rodrigo, Ian Martins, Xiaozhong Guo , Xingshun Qi

$435.95 $392.34

Hardback

See Also

Contact Abbeys

Contact Galaxy

Contact Language

Contact Us

About ABBEY'S